Systematic investigation of non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs)

被引：6
作者：
Beyer, A
Lawtrakul, L
Hannongbua, S
Wolschann, P
机构：
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Thammasat Univ, SIIT, Dept Common & Grad Studies, Pathum Thani 12121, Thailand
[3] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[4] Inst Theoret Chem & Struct Biol, A-1090 Vienna, Austria
来源：
MONATSHEFTE FUR CHEMIE | 2004年 / 135卷 / 08期
关键词：
non-nucleoside reverse transcriptase inhibitors (NNRTIs); inhibition mechanism; viral mutation; drug resistance;
D O I：
10.1007/s00706-004-0173-y
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The 44 crystal structures of NNRTIs complexed with HIV-1 reverse transcriptase (RT) have been analyzed in detail especially the orientation geometries and the distances between inhibitor molecules and surrounding amino acids. In general, various NNIs bind to the same region of the HIV-1 RT in the palm subdomain of p66, but subtle differences in individual interactions between RT and its inhibitors can be detected by comparison of all structures in this study.
引用
收藏
页码：1047 / 1059
页数：13
相关论文
共 34 条
  • [21] Lawtrakul L., 1999, SCI PHARM, V67, P43
  • [22] INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
    MERLUZZI, VJ
    HARGRAVE, KD
    LABADIA, M
    GROZINGER, K
    SKOOG, M
    WU, JC
    SHIH, CK
    ECKNER, K
    HATTOX, S
    ADAMS, J
    ROSEHTHAL, AS
    FAANES, R
    ECKNER, RJ
    KOUP, RA
    SULLIVAN, JL
    [J]. SCIENCE, 1990, 250 (4986) : 1411 - 1413
  • [23] A NOVEL LEAD FOR SPECIFIC ANTI-HIV-1 AGENTS - 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE
    MIYASAKA, T
    TANAKA, H
    BABA, M
    HAYAKAWA, H
    WALKER, RT
    BALZARINI, J
    DECLERCQ, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) : 2507 - 2509
  • [24] *OXF MOL LTD, 1997, TSAR 3 1 US GUID
  • [25] POTENT AND HIGHLY SELECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INHIBITION BY A SERIES OF ALPHA-ANILINOPHENYLACETAMIDE DERIVATIVES TARGETED AT HIV-1 REVERSE-TRANSCRIPTASE
    PAUWELS, R
    ANDRIES, K
    DEBYSER, Z
    VAN DAELE, P
    SCHOLS, D
    STOFFELS, P
    DEVREESE, K
    WOESTENBORGHS, R
    VANDAMME, AM
    JANSSEN, CGM
    ANNE, J
    CAUWENBERGH, G
    DESMYTER, J
    HEYKANTS, J
    JANSSEN, MAC
    DE CLERCQ, E
    JANSSEN, PAJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1711 - 1715
  • [26] Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors
    Pungpo, P
    Hannongbua, S
    Wolschann, P
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) : 1661 - 1677
  • [27] Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz
    Re, MC
    Monari, P
    Bon, I
    Borderi, M
    Gibellini, D
    Schiavone, P
    Vitone, F
    Furlini, G
    La Placa, M
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (03) : 223 - 226
  • [28] Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors
    Ren, J
    Nichols, C
    Bird, L
    Chamberlain, P
    Weaver, K
    Short, S
    Stuart, DI
    Stammers, DK
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 312 (04) : 795 - 805
  • [29] Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase
    Ren, J
    Milton, J
    Weaver, KL
    Short, SA
    Stuart, DI
    Stammers, DK
    [J]. STRUCTURE, 2000, 8 (10) : 1089 - 1094
  • [30] HIGH-RESOLUTION STRUCTURES OF HIV-1 RT FROM 4 RT-INHIBITOR COMPLEXES
    REN, JS
    ESNOUF, R
    GARMAN, E
    SOMERS, D
    ROSS, C
    KIRBY, I
    KEELING, J
    DARBY, G
    JONES, Y
    STUART, D
    STAMMERS, D
    [J]. NATURE STRUCTURAL BIOLOGY, 1995, 2 (04): : 293 - 302
1234